临床医生导向的综合精密瘤学的需求分析决策支持工具:定性描述性研究
Sheng Zheng1, Yi Feng2, Jieran Long3
1College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.
JMIR human factors
|September 8, 2025
概括
精密瘤决策支持 (PODS) 工具需要加强知识获取和临床上下文化. 了解临床医生的需求对于开发有效的PODS工具来改善癌症护理至关重要.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 基因组学就是基因组学.
背景情况:
- 下一代测序推进了精准医学,增加了瘤学知识.
- 医疗保健专业人员努力将复杂的癌症数据整合到临床工作流程中.
- 目前精确瘤决策支持 (PODS) 工具的功能有限,需要更好的需求评估.
研究的目的:
- 探索临床医生对综合PODS工具的需求和期望.
- 确定提高PODS工具可用性和临床影响的基本特征.
主要方法:
- 北京大学癌症医院的定性调查.
- 在多学科团队会议期间143个结构化的参与者观察.
- 与各种瘤专家进行了17次深入的半结构面试.
- 专题分析以确定功能要求并制定框架.
主要成果:
- 临床医生需要更好地获得瘤学知识,包括治疗选择和诊断见解.
- 需要临床上下文化和对试验和药物的资源导航.
- 需要加强决策支持,包括数据合成,可视化和检索功能.
结论:
- PODS工具是复杂的决策支持系统,需要根据临床医生的需求进行改进.
- 收集了可操作的见解,以增强PODS工具,弥合基因组学进步和临床决策.
- 了解临床医生的观点对于PODS工具在精密瘤学中的实际采用和有效性至关重要.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.2K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.6K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
